Edwards Lifesciences Corporation Equity Securities without Readily Determinable Fair Value, Amount
Edwards Lifesciences Corporation (EW) had Equity Securities without Readily Determinable Fair Value, Amount of $104.90 million as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2024-11-06
- 2024-09-30: Equity Securities without Readily Determinable Fair Value, Amount $104.90M.
- 2023-12-31: Equity Securities without Readily Determinable Fair Value, Amount $87.60M.
| Period end | Equity Securities without Readily Determinable Fair Value, Amount |
|---|---|
| 2024-09-30 | $104.90M 10-Q · filed 2024-11-06 |
| 2023-12-31 | $87.60M 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |